ARISTOTLE CAPITAL BOSTON LLC
Q1 2024 Form 13-F

BOSTON, MASSACHUSETTS
CIK 0001633911 · CRD 173198 · SEC-registered investment adviser
Consolidated report · includes 1 manager since Q2 2023
$3.3B Reported Value Total

ARISTOTLE CAPITAL BOSTON, LLC reports 152 total accounts under management (AUM). There are 152 discretionary accounts valued at $3,334,302,462, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Source: Form ADV filed 2026-03-20
Reported value
$3.3B
Quarter over quarter
+4.6%
Holdings
128
Top-10 concentration
20.2%

Filing Structure

Reports holdings for

Holdings reported by

  • Premia Global Advisors LLC (not a 13F filer in our records) · Q1 2018 – Q1 2018 · declared by one filing

Key People

Form ADV owners & control persons
David Michael Adams
OWNER, CHIEF EXECUTIVE OFFICER, PORTFOLIO MANAGER
John Mcpherson
OWNER, PRESIDENT, PORTFOLIO MANAGER
Mark Bernard Babka
OWNER, SENIOR RESEARCH ANALYST

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2024 13F record

Q1 2024 13F filing summary

Q1 2024 Form 13F portfolio summary
Period of report March 31, 2024
Filed May 15, 2024
Form 13F-HR
Reported value $3.3B
Positions 128
Change in reported value +0.7%
New positions 1
Exited positions 4
Position turnover 3.8%
Top-10 concentration 20.2%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
119 $1.5B
Q1 2026 13F
Filed May 15, 2026
122 $1.6B
Q4 2025 13F
Filed Feb 17, 2026
125 $1.8B
Q3 2025 13F
Filed Nov 14, 2025
127 $1.9B
Q2 2025 13F
Filed Aug 14, 2025
127 $2.0B
Q1 2025 13F
Filed May 15, 2025
125 $2.0B
Q4 2024 13F
Filed Feb 14, 2025
127 $2.7B
Q3 2024 13F
Filed Nov 14, 2024
127 $3.0B
Q2 2024 13F
Filed Aug 14, 2024
126 $3.0B
Q1 2024 13F
Filed May 15, 2024
128 $3.3B
Q4 2023 13F
Filed Feb 14, 2024
131 $3.3B
Q3 2023 13F
Filed Nov 14, 2023
129 $3.1B
Q2 2023 13F
Filed Aug 14, 2023
132 $3.3B
Q1 2023 13F
Filed May 15, 2023
132 $3.2B
Q4 2022 13F
Filed Feb 14, 2023
133 $3.2B
Q3 2022 13F
Filed Nov 14, 2022
133 $3.0B
Q2 2022 13F
Filed Aug 15, 2022
133 $3.4B
Q1 2022 13F
Filed May 16, 2022
133 $4.0B
Q4 2021 13F
Filed Feb 14, 2022
134 $4.3B
Q3 2021 13F
Filed Nov 15, 2021
136 $4.3B

27 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2024

Largest Q1 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 AER AERCAP HOLDINGS NV $77.4M 2.35%
2 ITRI ITRON INC $72.5M 2.2%
3 ACHC ACADIA HEALTHCARE COMPANY IN $71.8M 2.18%
4 DY DYCOM INDS INC $66.4M 2.02%
5 HURN HURON CONSULTING GROUP INC $66.4M 2.02%
6 MMSI MERIT MED SYS INC $64.6M 1.96%
7 MTSI MACOM TECH SOLUTIONS HLDGS I $64.2M 1.95%
8 ASGN ASGN INC $60.2M 1.83%
9 AZEK AZEK CO INC $60.2M 1.83%
10 CHE CHEMED CORP NEW $60.2M 1.83%
11 AEIS ADVANCED ENERGY INDS $53.6M 1.63%
12 BDC BELDEN INC $51.3M 1.56%
13 PBH PRESTIGE CONSMR HEALTHCARE I $51.1M 1.55%
14 WAB WABTEC $48.0M 1.46%
15 AIN ALBANY INTL CORP $47.8M 1.45%
16 HQY HEALTHEQUITY INC $47.6M 1.44%
17 SUM SUMMIT MATLS INC $47.3M 1.43%
18 ACIW ACI WORLDWIDE INC $47.2M 1.43%
19 CRI CARTERS INC $46.9M 1.42%
20 BRP BRP GROUP INC $44.7M 1.36%

Values as reported on the Q1 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings